Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin

Experimental and Therapeutic Medicine

Volumn 2, Issue 4, 2011, Pages 607-613

  Tonan, Tatsuyuki ^a   Fujimoto, Kiminori ^a   Qayyum, Aliya ^e   Azuma, Sanae ^a   Ishibashi, Masatoshi ^a   Ueno, Takato ^b   Ono, Noriyuki ^d   Akiyoshi, Junji ^c   Matsushita, Sunao ^d   Hayabuchi, Naofumi ^a   Kawaguchi, Takumi ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Internal Medicine   (Japan)

^d Chikugo City Hospital   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic viral hepatitis; Hepatic function reserve; Kupffer cell function; Scintigraphy using technetium 99m labelled galactosyl human serum albumin; Superparamagnetic iron oxide enhanced magnetic resonance imaging

Indexed keywords

GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; HUMAN SERUM ALBUMIN TC 99M; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL FUNCTION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; KUPFFER CELL; LIVER CELL; LIVER CIRRHOSIS; LIVER SCINTISCANNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; VIRUS HEPATITIS;

EID: 79958054610     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.255     Document Type: Article

References (36)

1. Child CG and Turcotte JG: Surgery and portal hypertension. Major Probl Clin Surg 1: 1-85, 1964.
2. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R: Transection of the oesophagus for bleeding oesoph-ageal varices. Br J Surg 60: 646-649, 1973.
3. Schneider PD: Preoperative assessment of liver function. Surg Clin North Am 84: 355-373, 2004.
4. Lucey MR, Brown KA, Everson GT, et al: Minimal criteria for placement of adults on the liver transplant waiting list. Transplantation 66: 956-962, 1998.
5. Tygstrup N: The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand 175: 281-289, 1964.
6. Hepner GW and Vesell ES: Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. N Engl J Med 291: 134-147, 1975.
7. Kawamura H, Kamiyama T, Nakagawa T, et al: Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol 8: 1235-1241, 2008.
8. Moody FG, Rikkers LF and Aldrete JS: Estimation of the functional reserve of human liver. Ann Surg 180: 592-598, 1972.
9. Yamanaka N, Okamoto E, Kuwata K and Tanaka N: A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 200: 658-663, 1984.
10. Fujioka H, Kawashita Y, Kamohara Y, et al: Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 28: 329-333, 1999.
11. Sasaki N, Shiomi S, Iwata Y, et al: Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med 40: 1652-1656, 1999.
12. Kawamura E, Shiomi S, Ishizu H, et al: Natural course of change in hepatic functional reserve in patients with chronic liver disease evaluated by scintigraphy with GSA. Hepatol Res 27: 129-135, 2003.
13. Shiomi S, Kuroki T, Kuriyama M, et al: Evaluation of fuminant hepatic failure by scintigraphy with technetium-99m-GSA. J Nucl Med 38: 79-82, 1997.
14. Hakawa SK and Tanaka Y: A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood fow and hepatic binding receptor. J Nucl Med 32: 2233-2240, 1991.
15. Sugai Y, Komatani A, Hosoya T and Takahashi K: Analysis of the early blood kinetics of 99mTc-GSA and its verifcation: new one-compartment model and regression equation. Nucl Med Commun 22: 773-778, 2001.
16. Sugahara K, Togashi H, Takahashi K, et al: Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using Tc-GSA SPECT. Hepatology 38: 1401-1409, 2003.
17. Nanashima A, Yamaguchi H, Shibasaki S, et al: Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatec-tomy: clinical evaluation and patient outcome. Hepatol Res 28: 184-190, 2004.
18. Tonan T, Fujimoto K, Azuma S, et al: Evaluation of small (< or =2 cm) dysplastic nodules and well-differentiated hepatocellular carcinomas with ferucarbotran-enhanced MRI in a 1.0-T MRI unit: utility of T2-weighted gradient echo sequences with an intermediate-echo time. Eur J Radiol 64: 133-139, 2007.
19. Elizondo G, Weissleder R, Stark DD, et al: Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 174: 797-801, 1990.
20. Clement O, Frija G, Chambon C, et al: Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging. Radiology 180: 31-36, 1991.
21. Kato N, Ihara S, Tsujimoto T and Miyazawa T: Effect of resovist on rats with different severities of liver cirrhosis. Invest Radiol 222: 661-666, 2002.
22. Tanimoto A, Yuasa Y, Shinmoto H, et al: Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function. Radiology 222: 661-666, 2002.
23. Hundt W, Petsch R, Heimberger T and Reiser H: Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis. Eur Radiol 10: 409-416, 2000.
24. Gandon Y, Olivié D, Guyader D, et al: Non-invasive assessment of hepatic iron stores by MRI. Lancet 31: 357-362, 2004.
25. Kudo M, Todo A, Ikekubo K, et al: Functional hepatic imaging with receptor-binding radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 26: 734-741, 1991.
26. Bland JM and Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986.
27. Waxman AD: Scintigraphic evaluation of diffuse hepatic disease. Semin Nucl Med 12: 75-88, 1982.
28. Klingensmith WC III, Fritzberg AR, Zerbe GO and Koep LJ: Relative role of Tc-99m-diethyl-IDA and Tc-99m-sulfur colloid in the evaluation of liver function. Clin Nucl Med 5: 341-346, 1980.
29. Asanuma T, Ono M, Kubota K, et al: Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in nonalcoholic fatty liver disease. Gut 59: 258-266, 2010.
30. Tsujimoto T, Kawaratani H, Kitazawa T, et al: Decreased phago-cytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model. World J Gastroenterol 14: 6036-6043, 2008.
31. Kira T, Tomiguchi S, Kira M, Ohyama Y and Takahashi M: Quantitative evaluation of the hepatic functional reserve using technetium-99m DTPA-galactosyl human serum albumin before and after transjugular intrahepatic portosystemic shunt. Eur J Nucl Med 24: 1268-1272, 1997.
32. Osada H, Honda N, Takahashi T, et al: Relationship between (99m)Tc-GSA scintigraphic indices of liver function reserve and portal circulation in patients with chronic liver disease. Ann Nucl Med 21: 245-249, 2007.
33. Aguirre DA, Behling CA, Alpert E, Hassanein TI and Sirlin CB: Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 239: 425-437, 2006.
34. Lucidarme O, Baleston F, Cadi M, et al: Non-invasive detection of liver fibrosis: Is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol 13: 467-474, 2003.
35. Engström-Laurent A, Laurent UB, Lilja K and Laurent TC: Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 45: 497-504, 1985.
36. Tsukamoto T, Yamamoto T, Ikebe T, et al: Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Hepatogastroenterology 51: 777-780, 2004.